Healthcare Sector Stocks
The Healthcare sector has a total of 1056 stocks, with a combined market cap of $9.43 trillion, total revenue of $4.67 trillion and a weighted average PE ratio of 50.40.
Market Cap
9.43T
Revenue
4.67T
Profits
187.12B
PE Ratio
50.40
Profit Margin
4.01%
Dividend Yield
0.38%
1055 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.03T | 0.28% | 2,522,523 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 653.54B | 2.01% | 6,035,314 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 459.43B | 1.39% | 3,866,739 | 64.39B |
| 4 | MRK | Merck & Co., Inc. | 369.73B | 1.42% | 9,866,567 | 66.57B |
| 5 | UNH | UnitedHealth Group Incorporated | 355.72B | 1.77% | 3,717,252 | 450.53B |
| 6 | NVS | Novartis AG | 306.77B | 6.04% | 4,334,984 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 250.99B | 0.21% | 2,598,488 | 61.37B |
| 8 | AMGN | Amgen Inc. | 236.86B | 1.92% | 2,359,103 | 38.10B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 222.03B | -2.69% | 1,385,067 | 46.34B |
| 10 | NVO | Novo Nordisk A/S | 201.62B | -0.46% | 9,355,998 | 50.34B |
| 11 | ABT | Abbott Laboratories | 188.49B | -1.30% | 7,229,417 | 46.59B |
| 12 | GILD | Gilead Sciences, Inc. | 185.89B | 2.45% | 4,870,767 | 30.46B |
| 13 | PFE | Pfizer Inc. | 162.73B | 0.32% | 42,493,395 | 63.70B |
| 14 | DHR | Danaher Corporation | 145.47B | -3.10% | 3,149,241 | 25.11B |
| 15 | VRTX | Vertex Pharmaceuticals Incorporated | 138.81B | 0.57% | 735,119 | 12.59B |
| 16 | BMY | Bristol-Myers Squibb Company | 136.70B | 0.16% | 6,933,599 | 49.19B |
| 17 | ISRG | Intuitive Surgical, Inc. | 130.45B | -2.02% | 1,849,101 | 11.03B |
| 18 | CVS | CVS Health Corporation | 124.83B | 3.93% | 8,614,488 | 412.65B |
| 19 | SYK | Stryker Corporation | 121.75B | -1.98% | 2,138,369 | 25.84B |
| 20 | MDT | Medtronic plc | 117.81B | 1.53% | 18,840,840 | 37.54B |
| 21 | SNY | Sanofi | 106.75B | 0.02% | 2,015,192 | 55.89B |
| 22 | MCK | McKesson Corporation | 105.72B | 2.53% | 787,987 | 410.98B |
| 23 | GSK | GSK plc | 101.45B | 0.82% | 3,272,440 | 44.05B |
| 24 | HCA | HCA Healthcare, Inc. | 89.54B | -0.21% | 1,258,146 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 87.41B | 2.67% | 1,101,999 | 201.11B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 82.26B | 3.10% | 682,806 | 15.53B |
| 27 | CI | The Cigna Group | 74.80B | 2.53% | 1,304,791 | 282.38B |
| 28 | BSX | Boston Scientific Corporation | 69.68B | -0.46% | 12,004,264 | 21.00B |
| 29 | ARGX | argenx SE | 64.25B | -0.31% | 192,945 | 5.32B |
| 30 | COR | Cencora, Inc. | 63.16B | 2.28% | 1,518,597 | 332.77B |
| 31 | MRNA | Moderna, Inc. | 61.59B | 9.93% | 25,831,744 | 2.23B |
| 32 | TAK | Takeda Pharmaceutical Company Limited | 58.30B | 1.39% | 1,899,445 | 28.42B |
| 33 | CAH | Cardinal Health, Inc. | 55.67B | 2.02% | 1,336,387 | 254.25B |
| 34 | EW | Edwards Lifesciences Corporation | 52.30B | -0.01% | 2,539,930 | 6.51B |
| 35 | BDX | Becton, Dickinson and Company | 50.97B | -0.53% | 1,279,743 | 22.48B |
| 36 | HUM | Humana Inc. | 47.42B | 3.04% | 1,059,658 | 145.68B |
| 37 | NTRA | Natera, Inc. | 46.24B | -0.37% | 1,208,846 | 2.71B |
| 38 | MDLN | Medline Inc. | 46.16B | 0.23% | 7,943,882 | 29.94B |
| 39 | VEEV | Veeva Systems Inc. | 45.21B | -2.26% | 1,219,611 | 3.46B |
| 40 | RVMD | Revolution Medicines, Inc. | 44.98B | 2.09% | 1,834,261 | - |
| 41 | HLN | Haleon plc | 44.08B | 0.40% | 11,244,021 | 14.80B |
| 42 | IDXX | IDEXX Laboratories, Inc. | 42.95B | -2.07% | 458,287 | 4.55B |
| 43 | IQV | IQVIA Holdings Inc. | 42.52B | -1.09% | 1,240,019 | 16.98B |
| 44 | A | Agilent Technologies, Inc. | 42.27B | -2.36% | 2,715,527 | 7.37B |
| 45 | TEVA | Teva Pharmaceutical Industries Limited | 42.17B | 0.39% | 3,515,716 | 17.32B |
| 46 | ONC | BeOne Medicines AG | 40.78B | -0.26% | 351,276 | 6.13B |
| 47 | WAT | Waters Corporation | 39.87B | -2.12% | 517,209 | 4.64B |
| 48 | RPRX | Royalty Pharma plc | 35.83B | 1.48% | 2,629,306 | 2.54B |
| 49 | ALC | Alcon Inc. | 34.73B | -0.43% | 1,404,981 | 10.86B |
| 50 | DXCM | DexCom, Inc. | 34.02B | -1.01% | 2,151,646 | 4.97B |
| 51 | RMD | ResMed Inc. | 33.37B | -3.64% | 987,079 | 5.65B |
| 52 | ALNY | Alnylam Pharmaceuticals, Inc. | 32.93B | 2.25% | 1,941,271 | 4.80B |
| 53 | CNC | Centene Corporation | 32.22B | 1.38% | 4,564,221 | 180.30B |
| 54 | ZTS | Zoetis Inc. | 31.92B | 0.19% | 4,001,473 | 9.53B |
| 55 | BIIB | Biogen Inc. | 31.92B | -0.28% | 785,497 | 10.03B |
| 56 | GEHC | GE HealthCare Technologies Inc. | 31.81B | -1.14% | 2,776,039 | 21.27B |
| 57 | ILMN | Illumina, Inc. | 31.28B | -3.04% | 1,501,398 | 4.49B |
| 58 | MTD | Mettler-Toledo International Inc. | 27.57B | -2.08% | 168,552 | 4.13B |
| 59 | LH | Labcorp Holdings Inc. | 26.57B | -1.52% | 571,751 | 14.35B |
| 60 | INSM | Insmed Incorporated | 26.54B | -0.25% | 1,419,286 | 1.14B |
| 61 | PHG | Koninklijke Philips N.V. | 26.12B | 0.08% | 732,603 | 20.18B |
| 62 | DGX | Quest Diagnostics Incorporated | 26.07B | -1.70% | 813,393 | 11.56B |
| 63 | BNTX | BioNTech SE | 25.61B | 0.33% | 1,040,117 | 3.03B |
| 64 | INCY | Incyte Corporation | 25.34B | 1.45% | 1,191,994 | 5.82B |
| 65 | ROIV | Roivant Sciences Ltd. | 24.93B | -0.35% | 6,906,003 | 7.53M |
| 66 | WST | West Pharmaceutical Services, Inc. | 23.83B | -0.72% | 482,815 | 3.33B |
| 67 | STE | STERIS plc | 22.39B | -1.29% | 558,506 | 6.04B |
| 68 | GH | Guardant Health, Inc. | 22.06B | 3.39% | 2,437,498 | 1.18B |
| 69 | UTHR | United Therapeutics Corporation | 21.99B | 0.45% | 478,996 | 3.15B |
| 70 | THC | Tenet Healthcare Corporation | 21.41B | -0.03% | 816,023 | 21.81B |
| 71 | GMAB | Genmab A/S | 19.88B | 0.39% | 1,563,240 | 4.13B |
| 72 | VTRS | Viatris Inc. | 19.10B | 0.73% | 6,527,493 | 14.74B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 18.96B | -0.64% | 1,393,339 | 8.51B |
| 74 | ASND | Ascendis Pharma A/S | 17.09B | -1.06% | 610,604 | 1.20B |
| 75 | MEDP | Medpace Holdings, Inc. | 16.28B | -1.81% | 179,868 | 2.78B |
| 76 | NBIX | Neurocrine Biosciences, Inc. | 15.93B | 1.77% | 878,439 | 3.37B |
| 77 | JAZZ | Jazz Pharmaceuticals plc | 15.82B | -2.78% | 1,072,824 | 4.60B |
| 78 | SOLV | Solventum Corporation | 15.48B | -0.12% | 1,112,751 | 8.31B |
| 79 | BBIO | BridgeBio Pharma, Inc. | 14.97B | -0.03% | 1,448,466 | 713.07M |
| 80 | RVTY | Revvity, Inc. | 14.13B | -1.62% | 3,056,575 | 2.91B |
| 81 | EXEL | Exelixis, Inc. | 14.10B | 4.12% | 2,413,531 | 2.44B |
| 82 | COO | The Cooper Companies, Inc. | 13.51B | -1.16% | 1,362,762 | 4.23B |
| 83 | CRL | Charles River Laboratories International, Inc. | 13.48B | -2.05% | 705,710 | 4.00B |
| 84 | BAX | Baxter International Inc. | 13.17B | -2.00% | 5,275,633 | 11.47B |
| 85 | PEN | Penumbra, Inc. | 12.71B | -0.16% | 150,764 | 1.50B |
| 86 | BMRN | BioMarin Pharmaceutical Inc. | 12.55B | -0.60% | 1,782,372 | 3.41B |
| 87 | ICLR | ICON Public Limited Company | 12.45B | -2.18% | 604,612 | 8.29B |
| 88 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.45B | -0.24% | 165,755 | 1.28B |
| 89 | BTSG | BrightSpring Health Services, Inc. | 12.32B | 1.30% | 1,485,939 | 14.37B |
| 90 | CORT | Corcept Therapeutics Incorporated | 12.26B | 0.03% | 1,112,265 | 830.81M |
| 91 | HALO | Halozyme Therapeutics, Inc. | 12.23B | 1.16% | 1,058,737 | 1.66B |
| 92 | SNN | Smith & Nephew plc | 12.18B | 0.73% | 2,782,347 | 6.30B |
| 93 | FMS | Fresenius Medical Care AG | 12.15B | - | 778,981 | 22.19B |
| 94 | EHC | Encompass Health Corporation | 12.04B | 1.53% | 1,034,842 | 6.21B |
| 95 | ELAN | Elanco Animal Health Incorporated | 11.95B | -0.04% | 3,946,857 | 5.02B |
| 96 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.69B | 0.42% | 1,330,721 | 669.50M |
| 97 | TECH | Bio-Techne Corporation | 11.32B | -0.18% | 2,903,320 | 1.22B |
| 98 | SMMT | Summit Therapeutics Inc. | 11.30B | 3.96% | 4,703,282 | - |
| 99 | TEM | Tempus AI, Inc. | 11.24B | -1.24% | 6,239,185 | 1.43B |
| 100 | DVA | DaVita Inc. | 11.23B | 0.07% | 672,631 | 14.01B |
| 101 | ALGN | Align Technology, Inc. | 11.01B | -3.02% | 576,464 | 4.14B |
| 102 | GMED | Globus Medical, Inc. | 10.81B | -1.09% | 1,054,387 | 3.14B |
| 103 | KRYS | Krystal Biotech, Inc. | 10.77B | 1.25% | 197,426 | 440.48M |
| 104 | ABVX | ABIVAX Société Anonyme | 10.68B | 1.74% | 991,486 | 5.67M |
| 105 | AXSM | Axsome Therapeutics, Inc. | 10.62B | 2.17% | 656,302 | 776.57M |
| 106 | MOH | Molina Healthcare, Inc. | 10.58B | 2.16% | 618,456 | 42.47B |
| 107 | GKOS | Glaukos Corporation | 10.42B | -1.59% | 507,238 | 612.84M |
| 108 | PODD | Insulet Corporation | 10.29B | -0.19% | 1,288,263 | 3.05B |
| 109 | RDY | Dr. Reddy's Laboratories Limited | 10.28B | 0.33% | 1,932,181 | 3.50B |
| 110 | APGE | Apogee Therapeutics, Inc. | 10.19B | - | 1,090,742 | - |
| 111 | BIO | Bio-Rad Laboratories, Inc. | 10.19B | -1.34% | 256,110 | 2.59B |
| 112 | UHS | Universal Health Services, Inc. | 10.06B | 0.36% | 522,677 | 18.11B |
| 113 | ENSG | The Ensign Group, Inc. | 10.01B | 0.55% | 217,019 | 5.49B |
| 114 | IONS | Ionis Pharmaceuticals, Inc. | 9.95B | -0.80% | 1,872,594 | 874.09M |
| 115 | CYTK | Cytokinetics, Incorporated | 9.93B | 0.69% | 1,899,653 | 67.67M |
| 116 | KYMR | Kymera Therapeutics, Inc. | 9.90B | 0.20% | 576,626 | 105.00M |
| 117 | PRAX | Praxis Precision Medicines, Inc. | 9.87B | 0.90% | 305,832 | 7.46M |
| 118 | HSIC | Henry Schein, Inc. | 9.87B | -1.43% | 718,251 | 13.60B |
| 119 | AVTR | Avantor, Inc. | 9.60B | -2.34% | 5,675,025 | 6.56B |
| 120 | RGEN | Repligen Corporation | 9.60B | -6.06% | 1,405,067 | 785.10M |
| 121 | PTGX | Protagonist Therapeutics, Inc. | 9.48B | -0.85% | 534,145 | 281.99M |
| 122 | OSCR | Oscar Health, Inc. | 9.20B | -0.43% | 5,008,195 | 15.32B |
| 123 | PCVX | Vaxcyte, Inc. | 9.05B | 0.12% | 1,441,443 | - |
| 124 | CRNX | Crinetics Pharmaceuticals, Inc. | 9.01B | - | - | 42.16M |
| 125 | QGEN | Qiagen N.V. | 8.97B | 0.23% | 2,554,682 | 2.10B |
| 126 | BRKR | Bruker Corporation | 8.54B | -3.41% | 2,028,255 | 3.50B |
| 127 | IBRX | ImmunityBio, Inc. | 8.34B | -1.01% | 6,465,675 | 165.79M |
| 128 | ATR | AptarGroup, Inc. | 8.32B | -0.53% | 418,155 | 3.93B |
| 129 | TWST | Twist Bioscience Corporation | 8.28B | -4.99% | 1,276,113 | 431.80M |
| 130 | IMVT | Immunovant, Inc. | 8.24B | -2.25% | 1,585,489 | - |
| 131 | HQY | HealthEquity, Inc. | 8.02B | 0.48% | 870,656 | 1.36B |
| 132 | TGTX | TG Therapeutics, Inc. | 7.96B | 3.30% | 3,198,319 | 799.54M |
| 133 | ALKS | Alkermes plc | 7.92B | 0.45% | 1,351,261 | 1.67B |
| 134 | TXG | 10x Genomics, Inc. | 7.81B | -3.96% | 1,963,698 | 616.91M |
| 135 | SYRE | Spyre Therapeutics, Inc. | 7.80B | -0.93% | 1,429,115 | - |
| 136 | HNGE | Hinge Health, Inc. | 7.26B | -2.74% | 1,730,040 | 720.06M |
| 137 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.21B | -1.31% | 332,051 | 239.92M |
| 138 | CAI | Caris Life Sciences, Inc. | 7.00B | -2.79% | 4,027,434 | 989.61M |
| 139 | GRFS | Grifols, S.A. | 6.88B | 0.13% | 284,246 | 8.48B |
| 140 | SRRK | Scholar Rock Holding Corporation | 6.81B | -1.60% | 763,187 | - |
| 141 | CGON | CG Oncology, Inc. | 6.72B | 0.93% | 876,134 | 6.23M |
| 142 | CHE | Chemed Corporation | 6.70B | -0.68% | 142,244 | 2.60B |
| 143 | PACS | PACS Group, Inc. | 6.67B | -0.40% | 637,384 | 5.55B |
| 144 | HIMS | Hims & Hers Health, Inc. | 6.64B | -3.85% | 7,304,679 | 2.58B |
| 145 | LNTH | Lantheus Holdings, Inc. | 6.58B | -0.08% | 1,380,180 | 1.56B |
| 146 | BLCO | Bausch + Lomb Corporation | 6.39B | 2.29% | 645,490 | 5.32B |
| 147 | MIRM | Mirum Pharmaceuticals, Inc. | 6.39B | 0.30% | 398,380 | 618.07M |
| 148 | BLTE | Belite Bio, Inc | 6.31B | 0.64% | 114,136 | - |
| 149 | MMED | MiniMed Group, Inc. | 6.30B | 10.66% | 6,075,888 | 3.22B |
| 150 | TVTX | Travere Therapeutics, Inc. | 6.19B | -0.86% | 1,074,583 | 591.33M |
| 151 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.19B | 0.83% | 387,221 | 840.85M |
| 152 | AMRX | Amneal Pharmaceuticals, Inc. | 6.16B | 1.20% | 1,364,822 | 3.12B |
| 153 | ORKA | Oruka Therapeutics, Inc. | 6.10B | -0.55% | 596,160 | - |
| 154 | COGT | Cogent Biosciences, Inc. | 6.02B | -0.91% | 1,480,641 | - |
| 155 | LQDA | Liquidia Corporation | 5.99B | -1.85% | 1,410,013 | 450.91M |
| 156 | DNTH | Dianthus Therapeutics, Inc. | 5.96B | 0.96% | 576,600 | 1.90M |
| 157 | TFX | Teleflex Incorporated | 5.95B | -1.11% | 565,007 | 2.25B |
| 158 | RDNT | RadNet, Inc. | 5.94B | -0.40% | 762,971 | 2.27B |
| 159 | PTCT | PTC Therapeutics, Inc. | 5.89B | 1.47% | 691,015 | 1.01B |
| 160 | ERAS | Erasca, Inc. | 5.86B | -6.26% | 6,708,101 | - |
| 161 | XENE | Xenon Pharmaceuticals Inc. | 5.81B | -0.37% | 418,794 | 7.50M |
| 162 | LGND | Ligand Pharmaceuticals Incorporated | 5.67B | 0.06% | 185,017 | 290.54M |
| 163 | STVN | Stevanato Group S.p.A. | 5.66B | -3.36% | 253,859 | 1.40B |
| 164 | CRSP | CRISPR Therapeutics AG | 5.49B | -0.28% | 890,824 | 13.39M |
| 165 | MMSI | Merit Medical Systems, Inc. | 5.41B | 0.02% | 678,999 | 1.58B |
| 166 | SHC | Sotera Health Company | 5.33B | -1.16% | 1,581,641 | 1.22B |
| 167 | DFTX | Definium Therapeutics, Inc. | 5.17B | -3.07% | 1,572,876 | - |
| 168 | ACAD | ACADIA Pharmaceuticals Inc. | 4.98B | -0.07% | 830,929 | 1.14B |
| 169 | WAY | Waystar Holding Corp. | 4.94B | -1.60% | 2,082,111 | 1.21B |
| 170 | PBLS | Parabilis Medicines, Inc. | 4.88B | 1.18% | 500,168 | 148.00K |
| 171 | LFST | LifeStance Health Group, Inc. | 4.81B | 1.94% | 3,465,906 | 1.58B |
| 172 | DOCS | Doximity, Inc. | 4.70B | -1.35% | 2,029,435 | 655.57M |
| 173 | DYN | Dyne Therapeutics, Inc. | 4.69B | -1.30% | 1,629,389 | - |
| 174 | HAE | Haemonetics Corporation | 4.64B | -1.09% | 633,647 | 1.35B |
| 175 | EWTX | Edgewise Therapeutics, Inc. | 4.59B | 1.15% | 1,040,507 | - |
| 176 | CELC | Celcuity Inc. | 4.50B | 3.28% | 1,161,861 | - |
| 177 | LIVN | LivaNova PLC | 4.42B | 0.44% | 585,412 | 1.47B |
| 178 | HTFL | HeartFlow, Inc. | 4.39B | 0.08% | 1,678,851 | 212.07M |
| 179 | BLLN | BillionToOne, Inc. | 4.36B | 1.82% | 426,295 | 397.41M |
| 180 | CON | Concentra Group Holdings Parent, Inc. | 4.32B | 0.44% | 587,204 | 2.29B |
| 181 | NVST | Envista Holdings Corporation | 4.28B | -1.84% | 2,171,494 | 2.86B |
| 182 | ICUI | ICU Medical, Inc. | 4.27B | -1.24% | 326,370 | 2.16B |
| 183 | ITGR | Integer Holdings Corporation | 4.26B | 0.11% | 1,173,273 | 1.84B |
| 184 | AMLX | Amylyx Pharmaceuticals, Inc. | 4.24B | 0.18% | 1,821,536 | -665.00K |
| 185 | ELVN | Enliven Therapeutics, Inc. | 4.24B | -0.05% | 1,056,446 | - |
| 186 | LEGN | Legend Biotech Corporation | 4.09B | 1.68% | 1,463,470 | 1.27B |
| 187 | INDV | Indivior Pharmaceuticals, Inc. | 4.08B | -1.06% | 2,094,931 | 1.33B |
| 188 | MANE | Veradermics, Incorporated | 4.07B | -0.91% | 548,759 | - |
| 189 | RLAY | Relay Therapeutics, Inc. | 4.05B | 0.60% | 1,598,443 | 10.35M |
| 190 | IRTC | iRhythm Holdings, Inc. | 4.03B | 2.87% | 597,770 | 825.34M |
| 191 | VKTX | Viking Therapeutics, Inc. | 3.93B | 2.72% | 1,679,416 | - |
| 192 | ADPT | Adaptive Biotechnologies Corporation | 3.88B | -2.33% | 1,621,011 | 308.08M |
| 193 | IDYA | IDEAYA Biosciences, Inc. | 3.85B | -0.37% | 587,802 | 234.13M |
| 194 | TLX | Telix Pharmaceuticals Limited | 3.81B | -2.16% | 186,286 | 890.79M |
| 195 | RCUS | Arcus Biosciences, Inc. | 3.78B | 1.47% | 1,528,495 | 117.00M |
| 196 | TNGX | Tango Therapeutics, Inc. | 3.77B | -2.15% | 1,544,312 | 53.81M |
| 197 | IOVA | Iovance Biotherapeutics, Inc. | 3.75B | 1.35% | 6,760,745 | 324.97M |
| 198 | DNLI | Denali Therapeutics Inc. | 3.72B | -2.08% | 1,431,669 | 3.60M |
| 199 | PLSE | Pulse Biosciences, Inc. | 3.72B | 3.50% | 1,133,570 | 1.19M |
| 200 | ABCL | AbCellera Biologics Inc. | 3.66B | -1.74% | 4,251,145 | 66.17M |
| 201 | OGN | Organon & Co. | 3.61B | - | 3,437,123 | 6.13B |
| 202 | GRAL | GRAIL, Inc. | 3.56B | 0.53% | 467,186 | 165.26M |
| 203 | OPCH | Option Care Health, Inc. | 3.54B | 0.81% | 1,560,109 | 5.69B |
| 204 | VCYT | Veracyte, Inc. | 3.49B | 0.56% | 873,012 | 561.90M |
| 205 | NHC | National HealthCare Corporation | 3.43B | 1.13% | 129,165 | 1.56B |
| 206 | GPCR | Structure Therapeutics Inc. | 3.36B | 2.66% | 816,627 | - |
| 207 | QURE | uniQure N.V. | 3.32B | -1.68% | 748,864 | 18.67M |
| 208 | TARS | Tarsus Pharmaceuticals, Inc. | 3.25B | -0.26% | 587,273 | 606.33M |
| 209 | CLDX | Celldex Therapeutics, Inc. | 3.08B | -0.98% | 542,484 | 158.00K |
| 210 | IMNM | Immunome, Inc. | 3.07B | -1.26% | 700,168 | 4.02M |
| 211 | IRON | Disc Medicine, Inc. | 3.02B | 0.03% | 549,435 | - |
| 212 | WRBY | Warby Parker Inc. | 2.99B | -1.67% | 2,001,261 | 911.61M |
| 213 | ARQT | Arcutis Biotherapeutics, Inc. | 2.99B | -0.92% | 1,101,734 | 463.98M |
| 214 | NAMS | NewAmsterdam Pharma Company N.V. | 2.98B | -1.66% | 714,358 | 7.12M |
| 215 | AVAH | Aveanna Healthcare Holdings Inc. | 2.94B | 0.30% | 2,053,585 | 2.60B |
| 216 | MBX | MBX Biosciences, Inc. | 2.93B | -1.09% | 416,086 | - |
| 217 | BEAM | Beam Therapeutics Inc. | 2.90B | -1.39% | 889,435 | 156.04M |
| 218 | TMDX | TransMedics Group, Inc. | 2.85B | -3.10% | 883,990 | 668.47M |
| 219 | BKD | Brookdale Senior Living Inc. | 2.84B | 0.93% | 6,897,180 | 2.93B |
| 220 | ZLAB | Zai Lab Limited | 2.84B | -0.63% | 979,940 | 449.61M |
| 221 | ALHC | Alignment Healthcare, Inc. | 2.82B | 1.42% | 4,123,820 | 4.58B |
| 222 | RGC | Regencell Bioscience Holdings Limited | 2.73B | -0.18% | 102,533 | - |
| 223 | ATAI | AtaiBeckley Inc. | 2.72B | - | 5,952,510 | 4.47M |
| 224 | NRIX | Nurix Therapeutics, Inc. | 2.70B | 1.01% | 1,597,357 | 36.77M |
| 225 | AXGN | Axogen, Inc. | 2.68B | -1.73% | 596,567 | 251.17M |
| 226 | SLS | SELLAS Life Sciences Group, Inc. | 2.67B | -0.90% | 5,911,667 | - |
| 227 | PRVA | Privia Health Group, Inc. | 2.64B | 0.73% | 1,068,791 | 2.36B |
| 228 | ACHC | Acadia Healthcare Company, Inc. | 2.63B | 2.50% | 1,451,054 | 3.37B |
| 229 | VRDN | Viridian Therapeutics, Inc. | 2.61B | -0.56% | 998,384 | 71.13M |
| 230 | SUPN | Supernus Pharmaceuticals, Inc. | 2.54B | -1.06% | 757,781 | 830.44M |
| 231 | NEOG | Neogen Corporation | 2.54B | 0.69% | 2,019,260 | 870.40M |
| 232 | RARE | Ultragenyx Pharmaceutical Inc. | 2.54B | 2.38% | 1,872,067 | 717.00M |
| 233 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.53B | 2.27% | 3,367,135 | 940.61M |
| 234 | CDNA | CareDx, Inc. | 2.53B | -2.27% | 1,247,928 | 458.09M |
| 235 | WGS | GeneDx Holdings Corp. | 2.53B | - | 342,086 | 454.43M |
| 236 | PBH | Prestige Consumer Healthcare Inc. | 2.49B | 1.66% | 592,569 | 1.10B |
| 237 | ATRC | AtriCure, Inc. | 2.49B | 1.18% | 718,137 | 569.62M |
| 238 | VERA | Vera Therapeutics, Inc. | 2.47B | 0.44% | 4,070,016 | - |
| 239 | GRDN | Guardian Pharmacy Services, Inc. | 2.46B | 4.80% | 537,409 | 1.46B |
| 240 | PGEN | Precigen, Inc. | 2.46B | -1.01% | 2,806,113 | 85.72M |
| 241 | PHVS | Pharvaris N.V. | 2.45B | 0.92% | 394,435 | - |
| 242 | NKTR | Nektar Therapeutics | 2.45B | 0.52% | 334,105 | 54.59M |
| 243 | BHC | Bausch Health Companies Inc. | 2.42B | 1.57% | 2,562,897 | 10.85B |
| 244 | HRMY | Harmony Biosciences Holdings, Inc. | 2.40B | 4.75% | 894,900 | 959.90M |
| 245 | BHVN | Biohaven Ltd. | 2.38B | 3.08% | 2,480,254 | - |
| 246 | TRVI | Trevi Therapeutics, Inc. | 2.36B | -0.18% | 945,060 | - |
| 247 | NUVB | Nuvation Bio Inc. | 2.33B | -0.30% | 4,844,279 | 169.90M |
| 248 | RAPP | Rapport Therapeutics, Inc. | 2.33B | -0.23% | 148,596 | 20.00M |
| 249 | KOD | Kodiak Sciences Inc. | 2.32B | -0.78% | 391,609 | - |
| 250 | OCUL | Ocular Therapeutix, Inc. | 2.32B | 0.76% | 1,578,327 | 52.06M |
| 251 | CLOV | Clover Health Investments, Corp. | 2.28B | 3.61% | 3,564,304 | 2.48B |
| 252 | UFPT | UFP Technologies, Inc. | 2.28B | -1.31% | 141,926 | 631.64M |
| 253 | TRLV | Trulieve Cannabis Corp. | 2.26B | 2.00% | 1,380,547 | 1.14B |
| 254 | MLYS | Mineralys Therapeutics, Inc. | 2.26B | -0.39% | 728,424 | - |
| 255 | SRPT | Sarepta Therapeutics, Inc. | 2.25B | 1.43% | 2,623,726 | 1.97B |
| 256 | NEO | NeoGenomics, Inc. | 2.24B | -2.57% | 1,318,286 | 766.30M |
| 257 | MESO | Mesoblast Limited | 2.20B | -1.55% | 169,082 | 120.25M |
| 258 | BFLY | Butterfly Network, Inc. | 2.18B | 3.68% | 5,611,211 | 112.14M |
| 259 | PVLA | Palvella Therapeutics, Inc. | 2.17B | -1.34% | 119,939 | - |
| 260 | XRAY | DENTSPLY SIRONA Inc. | 2.15B | -3.67% | 3,582,103 | 3.64B |
| 261 | AUPH | Aurinia Pharmaceuticals Inc. | 2.14B | -0.37% | 878,852 | 311.51M |
| 262 | KLRA | Kailera Therapeutics, Inc. | 2.13B | 6.56% | 1,207,722 | - |
| 263 | URGN | UroGen Pharma Ltd. | 2.12B | 0.70% | 584,223 | 188.73M |
| 264 | ZYME | Zymeworks Inc. | 2.11B | 0.88% | 483,063 | 37.13M |
| 265 | MD | Pediatrix Medical Group, Inc. | 2.10B | 0.91% | 715,423 | 1.95B |
| 266 | ADUS | Addus HomeCare Corporation | 2.10B | -0.10% | 208,079 | 1.48B |
| 267 | ADMA | ADMA Biologics, Inc. | 2.09B | -0.64% | 1,756,180 | 512.28M |
| 268 | ZBIO | Zenas BioPharma, Inc. | 2.08B | -1.05% | 432,254 | 1.00M |
| 269 | HCM | HUTCHMED (China) Limited | 2.08B | -1.73% | 74,512 | 549.12M |
| 270 | XNCR | Xencor, Inc. | 2.08B | 2.35% | 1,475,981 | 104.97M |
| 271 | VCEL | Vericel Corporation | 2.07B | 1.50% | 651,115 | 306.30M |
| 272 | ESTA | Establishment Labs Holdings Inc. | 2.07B | 0.32% | 372,267 | 245.82M |
| 273 | COAG | Hemab Therapeutics Holdings, Inc. | 2.06B | -3.74% | 318,514 | - |
| 274 | AGIO | Agios Pharmaceuticals, Inc. | 2.04B | 1.57% | 926,955 | 98.34M |
| 275 | ALMR | Alamar Biosciences, Inc. | 2.04B | -3.86% | 185,086 | 100.42M |
| 276 | GENB | Generate Biomedicines, Inc. | 2.03B | 3.41% | 1,048,822 | 26.48M |
| 277 | NVCR | NovoCure Limited | 2.02B | -1.53% | 800,361 | 699.19M |
| 278 | PRGO | Perrigo Company plc | 2.00B | -1.43% | 3,690,452 | 4.14B |
| 279 | STOK | Stoke Therapeutics, Inc. | 1.99B | -0.99% | 727,504 | 27.59M |
| 280 | ASTH | Astrana Health, Inc. | 1.98B | 1.29% | 301,328 | 3.84B |
| 281 | NBTX | Nanobiotix S.A. | 1.97B | -3.32% | 91,340 | 38.27M |
| 282 | PGNY | Progyny, Inc. | 1.97B | 0.27% | 765,237 | 1.31B |
| 283 | VIR | Vir Biotechnology, Inc. | 1.97B | 6.31% | 2,778,729 | 303.23M |
| 284 | IMCR | Immunocore Holdings plc | 1.90B | 1.49% | 790,814 | 430.78M |
| 285 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.90B | -4.45% | 2,698,379 | 208.78M |
| 286 | SGRY | Surgery Partners, Inc. | 1.89B | 5.11% | 3,962,462 | 3.37B |
| 287 | GHRS | GH Research PLC | 1.88B | 1.41% | 464,909 | - |
| 288 | ALVO | Alvotech | 1.87B | 0.96% | 1,029,062 | 494.61M |
| 289 | LKFT | Lakefront Biotherapeutics NV | 1.86B | 0.18% | 149,042 | 1.13B |
| 290 | TSHA | Taysha Gene Therapies, Inc. | 1.86B | 0.18% | 1,763,155 | 5.49M |
| 291 | LMAT | LeMaitre Vascular, Inc. | 1.85B | 1.00% | 346,539 | 262.43M |
| 292 | INBX | Inhibrx Biosciences, Inc. | 1.83B | -1.61% | 275,907 | 1.30M |
| 293 | CMPS | COMPASS Pathways plc | 1.83B | -2.00% | 1,891,541 | - |
| 294 | KARD | Kardigan, Inc. | 1.83B | -2.78% | 327,113 | - |
| 295 | PSNL | Personalis, Inc. | 1.82B | 1.67% | 3,619,033 | 69.67M |
| 296 | SNDX | Syndax Pharmaceuticals, Inc. | 1.79B | 4.20% | 1,405,859 | 252.25M |
| 297 | SNDA | Sonida Senior Living, Inc. | 1.79B | 0.80% | 670,593 | 481.07M |
| 298 | RXRX | Recursion Pharmaceuticals, Inc. | 1.79B | -2.06% | 9,996,546 | 54.86M |
| 299 | INSP | Inspire Medical Systems, Inc. | 1.78B | -2.33% | 351,710 | 898.74M |
| 300 | NTLA | Intellia Therapeutics, Inc. | 1.78B | -0.35% | 2,184,156 | 59.51M |
| 301 | SEPN | Septerna, Inc. | 1.76B | -1.23% | 263,952 | 98.88M |
| 302 | DMRA | Damora Therapeutics, Inc. | 1.74B | -0.14% | 272,798 | - |
| 303 | BLFS | BioLife Solutions, Inc. | 1.73B | -4.32% | 950,358 | 106.69M |
| 304 | ETON | Eton Pharmaceuticals, Inc. | 1.73B | -0.02% | 564,615 | 105.60M |
| 305 | BRVE | Braveheart Bio, Inc. | 1.69B | 3.06% | 342,869 | - |
| 306 | FTRE | Fortrea Holdings Inc. | 1.69B | -3.54% | 1,186,243 | 2.68B |
| 307 | NVAX | Novavax, Inc. | 1.67B | 8.00% | 10,040,575 | 413.80M |
| 308 | FRNM | Freenome, Inc. | 1.64B | 3.11% | 1,945,537 | 35.41M |
| 309 | ANAB | AnaptysBio, Inc. | 1.64B | -3.07% | 773,856 | 232.39M |
| 310 | SLBT | SL Science Holding Limited | 1.59B | 2.20% | 7,841 | 3.27M |
| 311 | OMCL | Omnicell, Inc. | 1.57B | -1.85% | 805,568 | 1.25B |
| 312 | AVLN | Avalyn Pharma Inc. | 1.56B | 1.58% | 183,577 | - |
| 313 | SDGR | Schrödinger, Inc. | 1.56B | 6.87% | 1,508,068 | 259.04M |
| 314 | PAHC | Phibro Animal Health Corporation | 1.56B | 1.67% | 370,175 | 1.52B |
| 315 | BCAX | Bicara Therapeutics Inc. | 1.55B | 1.30% | 429,860 | - |
| 316 | ARDT | Ardent Health, Inc. | 1.54B | 1.11% | 289,102 | 6.41B |
| 317 | ANIP | ANI Pharmaceuticals, Inc. | 1.54B | -1.82% | 580,542 | 978.38M |
| 318 | XERS | Xeris Biopharma Holdings, Inc. | 1.54B | -0.12% | 1,144,233 | 335.41M |
| 319 | INVA | Innoviva, Inc. | 1.52B | 1.49% | 798,742 | 440.00M |
| 320 | LBRX | LB Pharmaceuticals Inc | 1.52B | -0.34% | 201,987 | - |
| 321 | ABSI | Absci Corporation | 1.52B | -2.21% | 3,241,899 | 1.56M |
| 322 | TYRA | Tyra Biosciences, Inc. | 1.51B | 1.08% | 423,513 | - |
| 323 | AAPG | Ascentage Pharma Group International | 1.51B | -5.09% | 7,072 | 94.61M |
| 324 | HCSG | Healthcare Services Group, Inc. | 1.50B | -0.77% | 536,780 | 1.86B |
| 325 | APMD | Apnimed, Inc. | 1.49B | 2.29% | 376,557 | 120.15M |
| 326 | AVBP | ArriVent BioPharma, Inc. | 1.49B | 0.33% | 356,093 | - |
| 327 | TNDM | Tandem Diabetes Care, Inc. | 1.48B | -3.32% | 919,278 | 1.04B |
| 328 | REPL | Replimune Group, Inc. | 1.48B | 2.42% | 1,778,984 | - |
| 329 | MAZE | Maze Therapeutics, Inc. | 1.47B | -0.15% | 326,661 | 20.00M |
| 330 | KMTS | Kestra Medical Technologies, Ltd. | 1.47B | -2.45% | 319,325 | 95.13M |
| 331 | CNMD | CONMED Corporation | 1.47B | -1.46% | 269,001 | 1.37B |
| 332 | TRAX | First Tracks Biotherapeutics, Inc. | 1.47B | -1.60% | 557,548 | - |
| 333 | INNV | InnovAge Holding Corp. | 1.47B | 0.28% | 184,813 | 949.17M |
| 334 | AGL | agilon health, inc. | 1.47B | -0.48% | 99,394 | 5.92B |
| 335 | AKTS | Aktis Oncology, Inc. | 1.45B | 0.31% | 231,515 | 10.06M |
| 336 | ATEC | Alphatec Holdings, Inc. | 1.42B | -1.71% | 1,050,910 | 815.05M |
| 337 | LTGO | Latigo Biotherapeutics, Inc. | 1.41B | 1.09% | 288,898 | - |
| 338 | CGEM | Cullinan Therapeutics, Inc. | 1.40B | -1.27% | 546,141 | - |
| 339 | OMDA | Omada Health, Inc. | 1.40B | -6.97% | 1,429,651 | 309.76M |
| 340 | HROW | Harrow, Inc. | 1.39B | 0.16% | 359,718 | 275.59M |
| 341 | AZTA | Azenta, Inc. | 1.38B | -3.31% | 1,453,942 | 613.81M |
| 342 | ANRO | Alto Neuroscience, Inc. | 1.38B | -0.51% | 350,248 | - |
| 343 | MGTX | MeiraGTx Holdings plc | 1.36B | 2.75% | 880,480 | 397.50M |
| 344 | SVRA | Savara Inc. | 1.36B | -0.74% | 1,042,128 | - |
| 345 | OMER | Omeros Corporation | 1.36B | -0.21% | 2,042,703 | 38.42M |
| 346 | VOR | Vor Biopharma Inc. | 1.34B | 0.71% | 607,337 | - |
| 347 | JBIO | Jade Biosciences, Inc. | 1.34B | -1.59% | 516,639 | - |
| 348 | ORIC | ORIC Pharmaceuticals, Inc. | 1.34B | -0.77% | 646,365 | - |
| 349 | AORT | Artivion, Inc. | 1.32B | 0.37% | 675,100 | 471.47M |
| 350 | PNTG | The Pennant Group, Inc. | 1.32B | 2.67% | 242,944 | 1.10B |
| 351 | AMN | AMN Healthcare Services, Inc. | 1.30B | -2.16% | 574,324 | 3.43B |
| 352 | IART | Integra LifeSciences Holdings Corporation | 1.29B | -1.77% | 559,673 | 1.65B |
| 353 | IMTX | Immatics N.V. | 1.29B | -1.05% | 607,116 | 47.65M |
| 354 | DRTS | Alpha Tau Medical Ltd. | 1.29B | -1.06% | 465,407 | - |
| 355 | MLTX | MoonLake Immunotherapeutics | 1.29B | 0.53% | 662,549 | - |
| 356 | NUTX | Nutex Health Inc. | 1.28B | -0.75% | 232,322 | 846.72M |
| 357 | MNKD | MannKind Corporation | 1.28B | -0.75% | 2,234,753 | 393.63M |
| 358 | SPTX | Seaport Therapeutics, Inc. | 1.26B | -0.30% | 122,757 | - |
| 359 | CRON | Cronos Group Inc. | 1.24B | 0.30% | 1,116,238 | 179.09M |
| 360 | CERT | Certara, Inc. | 1.24B | -2.29% | 2,480,189 | 421.75M |
| 361 | ALMS | Alumis Inc. | 1.23B | -56.58% | 28,399,012 | 7.40M |
| 362 | GLUE | Monte Rosa Therapeutics, Inc. | 1.22B | 2.65% | 796,289 | 28.73M |
| 363 | CRVS | Corvus Pharmaceuticals, Inc. | 1.20B | 1.64% | 460,169 | - |
| 364 | PRCT | PROCEPT BioRobotics Corporation | 1.20B | -1.37% | 1,070,101 | 337.34M |
| 365 | ENOV | Enovis Corporation | 1.18B | -16.51% | 4,226,029 | 2.30B |
| 366 | GDRX | GoodRx Holdings, Inc. | 1.18B | -0.86% | 1,592,365 | 785.23M |
| 367 | STAA | STAAR Surgical Company | 1.18B | 4.12% | 737,816 | 339.59M |
| 368 | ODTX | Odyssey Therapeutics, Inc. | 1.17B | -0.08% | 172,831 | 99.00K |
| 369 | USPH | U.S. Physical Therapy, Inc. | 1.16B | 0.01% | 131,297 | 804.27M |
| 370 | JANX | Janux Therapeutics, Inc. | 1.15B | 3.68% | 980,545 | 24.00M |
| 371 | BVS | Bioventus Inc. | 1.15B | 0.15% | 642,890 | 581.85M |
| 372 | KURA | Kura Oncology, Inc. | 1.15B | 1.90% | 1,513,391 | 77.23M |
| 373 | SANA | Sana Biotechnology, Inc. | 1.15B | -1.03% | 1,696,810 | - |
| 374 | TDOC | Teladoc Health, Inc. | 1.14B | -1.26% | 3,448,420 | 2.49B |
| 375 | OPK | OPKO Health, Inc. | 1.13B | 3.40% | 3,056,003 | 587.90M |
| 376 | LMRI | Lumexa Imaging Holdings, Inc. | 1.12B | -0.26% | 196,740 | 1.04B |
| 377 | IVA | Inventiva S.A. | 1.11B | 1.92% | 840,967 | 7.94M |
| 378 | IRMD | IRADIMED CORPORATION | 1.10B | - | 68,437 | 86.34M |
| 379 | SLDB | Solid Biosciences Inc. | 1.06B | 3.13% | 803,305 | - |
| 380 | PCRX | Pacira BioSciences, Inc. | 1.06B | 2.20% | 729,463 | 746.16M |
| 381 | CSTL | Castle Biosciences, Inc. | 1.02B | 1.24% | 396,179 | 357.28M |
| 382 | AVTX | Avalo Therapeutics, Inc. | 1.02B | -2.02% | 606,643 | 59.00K |
| 383 | GMRS | GMR Solutions Inc. | 1.01B | 6.75% | 835,447 | 5.88B |
| 384 | ABUS | Arbutus Biopharma Corporation | 1.01B | 0.20% | 2,610,125 | 181.72M |
| 385 | IMMX | Immix Biopharma, Inc. | 1.00B | -0.14% | 1,277,412 | - |
| 386 | CADL | Candel Therapeutics, Inc. | 983.26M | -1.68% | 935,642 | - |
| 387 | WVE | Wave Life Sciences, Inc. | 979.33M | 1.43% | 3,000,394 | 65.37M |
| 388 | AMPH | Amphastar Pharmaceuticals, Inc. | 976.67M | 1.91% | 550,980 | 730.02M |
| 389 | LXRX | Lexicon Pharmaceuticals, Inc. | 974.45M | -2.67% | 1,987,900 | 41.47M |
| 390 | ATTO | Attovia Therapeutics, Inc. | 956.10M | 3.83% | 198,002 | 1.35M |
| 391 | GERN | Geron Corporation | 950.86M | -0.67% | 7,886,442 | 204.56M |
| 392 | DSGN | Design Therapeutics, Inc. | 947.49M | 0.33% | 476,964 | - |
| 393 | CBLL | CeriBell, Inc. | 943.33M | 2.50% | 325,980 | 101.96M |
| 394 | QDEL | QuidelOrtho Corporation | 942.91M | -4.71% | 892,838 | 2.67B |
| 395 | ARDX | Ardelyx, Inc. | 936.95M | -0.53% | 3,647,211 | 450.89M |
| 396 | ANNX | Annexon, Inc. | 927.04M | -1.01% | 1,472,606 | - |
| 397 | OLMA | Olema Pharmaceuticals, Inc. | 923.97M | 1.25% | 766,113 | - |
| 398 | SGP | SpyGlass Pharma, Inc. | 898.41M | 2.91% | 87,106 | - |
| 399 | FTH | Faeth Therapeutics, Inc. | 891.75M | 5.31% | 276,714 | - |
| 400 | SLN | Silence Therapeutics plc | 887.49M | 8.94% | 1,134,889 | 615.00K |
| 401 | RIGL | Rigel Pharmaceuticals, Inc. | 887.29M | 2.86% | 205,505 | 276.79M |
| 402 | ACRS | Aclaris Therapeutics, Inc. | 886.14M | -0.50% | 1,487,104 | 8.22M |
| 403 | TBPH | Theravance Biopharma, Inc. | 884.18M | -0.06% | 870,673 | 104.31M |
| 404 | ANL | Adlai Nortye Group Ltd. | 877.74M | -3.95% | 104,473 | 18.06M |
| 405 | HSTM | HealthStream, Inc. | 867.55M | 2.13% | 226,514 | 321.12M |
| 406 | INMD | InMode Ltd. | 863.94M | 0.47% | 799,934 | 374.63M |
| 407 | BBNX | Beta Bionics, Inc. | 857.95M | -4.41% | 564,367 | 119.01M |
| 408 | CLYM | Climb Bio, Inc. | 851.21M | 7.94% | 1,972,572 | - |
| 409 | ACHV | Achieve Life Sciences, Inc. | 848.95M | 3.90% | 1,652,227 | - |
| 410 | SIBN | SI-BONE, Inc. | 847.97M | -0.53% | 561,078 | 213.60M |
| 411 | HELP | Cybin Inc. | 847.50M | -1.36% | 1,140,718 | - |
| 412 | AVR | Anteris Technologies Global Corp. | 823.52M | -1.86% | 568,651 | 2.24M |
| 413 | GLAS | Glass House Brands Inc. | 800.12M | -4.93% | 691,288 | 176.98M |
| 414 | CTMX | CytomX Therapeutics, Inc. | 799.69M | 9.23% | 8,821,450 | 18.30M |
| 415 | PHAR | Pharming Group N.V. | 798.86M | -3.22% | 34,509 | 366.48M |
| 416 | DBVT | DBV Technologies S.A. | 794.50M | -2.89% | 250,611 | 5.04M |
| 417 | FDMT | 4D Molecular Therapeutics, Inc. | 792.75M | 1.70% | 707,964 | 92.01M |
| 418 | MNPR | Monopar Therapeutics Inc. | 789.15M | 5.04% | 95,175 | - |
| 419 | COLL | Collegium Pharmaceutical, Inc. | 781.33M | -2.48% | 1,407,000 | 808.21M |
| 420 | VREX | Varex Imaging Corporation | 778.47M | -0.11% | 763,134 | 865.00M |
| 421 | AHG | Akso Health Group | 771.03M | - | 3,354 | 13.83M |
| 422 | AURA | Aura Biosciences, Inc. | 770.53M | 3.48% | 534,541 | - |
| 423 | CBIO | Crescent Biopharma, Inc. | 767.42M | 8.01% | 788,171 | 11.88M |
| 424 | NGNE | Neurogene Inc. | 757.83M | 4.50% | 134,478 | 925.00K |
| 425 | OCS | Oculis Holding AG | 751.90M | -0.57% | 83,363 | 1.45M |
| 426 | NVCT | Nuvectis Pharma, Inc. | 751.33M | 1.45% | 176,925 | - |
| 427 | PHAT | Phathom Pharmaceuticals, Inc. | 745.85M | -1.88% | 885,493 | 239.66M |
| 428 | MPLT | MapLight Therapeutics, Inc. | 739.71M | 2.62% | 580,665 | - |
| 429 | OBX | Obsidian Therapeutics, Inc. | 738.28M | -2.68% | 79,264 | - |
| 430 | AHCO | AdaptHealth Corp. | 735.08M | -1.43% | 2,377,500 | 3.36B |
| 431 | PHR | Phreesia, Inc. | 731.85M | -3.03% | 506,255 | 495.59M |
| 432 | SOPH | SOPHiA GENETICS SA | 717.20M | 0.30% | 766,047 | 86.17M |
| 433 | ASMB | Assembly Biosciences, Inc. | 716.29M | 4.61% | 301,100 | 74.85M |
| 434 | ZVRA | Zevra Therapeutics, Inc. | 716.17M | 2.73% | 1,039,313 | 136.07M |
| 435 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 707.14M | 0.23% | 146,126 | - |
| 436 | IRWD | Ironwood Pharmaceuticals, Inc. | 705.57M | 0.47% | 1,456,286 | 389.32M |
| 437 | DRUG | Bright Minds Biosciences Inc. | 693.29M | -1.24% | 65,838 | - |
| 438 | STTK | Shattuck Labs, Inc. | 689.50M | -2.00% | 639,618 | 1.00M |
| 439 | VSTM | Verastem, Inc. | 689.19M | 5.40% | 2,079,541 | 87.53M |
| 440 | GYRE | Gyre Therapeutics, Inc. | 686.04M | -1.52% | 54,547 | 109.82M |
| 441 | ALLO | Allogene Therapeutics, Inc. | 685.80M | -0.75% | 4,037,911 | 4.64M |
| 442 | SSII | SS Innovations International, Inc. | 669.29M | -2.05% | 59,003 | 52.40M |
| 443 | CTEV | Claritev Corporation | 666.88M | -1.21% | 134,832 | 994.67M |
| 444 | AGMB | AgomAb Therapeutics NV | 666.82M | 2.81% | 241,315 | - |
| 445 | MDXG | MiMedx Group, Inc. | 658.84M | -0.44% | 762,367 | 355.17M |
| 446 | AQST | Aquestive Therapeutics, Inc. | 657.68M | 2.54% | 2,168,961 | 54.09M |
| 447 | ANGO | AngioDynamics, Inc. | 655.53M | -1.67% | 237,937 | 320.17M |
| 448 | CRMD | CorMedix Inc. | 653.17M | 1.45% | 880,481 | 462.25M |
| 449 | SGMT | Sagimet Biosciences Inc. | 652.67M | 2.34% | 752,203 | - |
| 450 | EVO | Evotec SE | 649.10M | -4.26% | 38,414 | 819.47M |
| 451 | OABI | OmniAb, Inc. | 645.53M | 1.37% | 1,156,203 | 38.46M |
| 452 | PRME | Prime Medicine, Inc. | 635.12M | -0.56% | 2,459,313 | 4.07M |
| 453 | CTNM | Contineum Therapeutics, Inc. | 622.63M | 1.91% | 212,119 | - |
| 454 | VALN | Valneva SE | 616.91M | 4.29% | 27,432 | 163.30M |
| 455 | RGNX | REGENXBIO Inc. | 615.24M | -1.89% | 783,802 | 174.48M |
| 456 | AUTL | Autolus Therapeutics plc | 614.84M | -1.70% | 1,477,729 | 117.39M |
| 457 | TECX | Tectonic Therapeutic, Inc. | 610.33M | 4.28% | 240,748 | - |
| 458 | TLRY | Tilray Brands, Inc. | 610.26M | -1.53% | 3,485,264 | 915.45M |
| 459 | ARVN | Arvinas, Inc. | 606.78M | 0.87% | 491,141 | 316.70M |
| 460 | STLN | Starling Oncology, Inc. | 605.38M | 0.51% | 947,280 | 587.24M |
| 461 | ALT | Altimmune, Inc. | 601.06M | -0.64% | 2,355,222 | 31.00K |
| 462 | KIDS | OrthoPediatrics Corp. | 600.53M | -1.33% | 139,798 | 252.72M |
| 463 | CTKB | Cytek Biosciences, Inc. | 600.52M | -3.35% | 629,428 | 206.71M |
| 464 | EOLS | Evolus, Inc. | 599.74M | -0.11% | 594,023 | 316.49M |
| 465 | EIKN | Eikon Therapeutics, Inc. | 589.32M | 4.02% | 333,492 | - |
| 466 | WEAV | Weave Communications, Inc. | 583.99M | -0.14% | 4,207,869 | 257.79M |
| 467 | CAPR | Capricor Therapeutics, Inc. | 581.97M | 1.01% | 6,308,556 | 11.13M |
| 468 | BLSM | BlossomHill Therapeutics, Inc. | 581.92M | 3.77% | 141,215 | - |
| 469 | SPRY | ARS Pharmaceuticals, Inc. | 573.81M | -3.83% | 1,358,006 | 116.93M |
| 470 | BWAY | BrainsWay Ltd. | 572.38M | -1.72% | 67,126 | 60.70M |
| 471 | DCTH | Delcath Systems, Inc. | 569.06M | -0.36% | 360,378 | 95.42M |
| 472 | PRLD | Prelude Therapeutics Incorporated | 565.44M | -1.96% | 538,439 | 22.42M |
| 473 | CABA | Cabaletta Bio, Inc. | 559.50M | 6.11% | 6,647,981 | - |
| 474 | PROK | ProKidney Corp. | 559.30M | -2.12% | 695,726 | 818.00K |
| 475 | ARTV | Artiva Biotherapeutics, Inc. | 551.48M | -0.18% | 268,855 | 251.00K |
| 476 | SCTX | Scribe Therapeutics Inc. | 547.07M | -5.04% | 165,446 | 36.28M |
| 477 | ZURA | Zura Bio Limited | 541.43M | 1.99% | 1,104,980 | - |
| 478 | FLGT | Fulgent Genetics, Inc. | 539.02M | 1.14% | 285,559 | 323.93M |
| 479 | OVID | Ovid Therapeutics Inc. | 539.02M | 3.37% | 1,294,889 | 1.58M |
| 480 | CERS | Cerus Corporation | 525.98M | -1.14% | 1,083,876 | 221.55M |
| 481 | KYTX | Kyverna Therapeutics, Inc. | 516.39M | -1.53% | 1,782,410 | - |
| 482 | NPCE | NeuroPace, Inc. | 505.94M | 0.61% | 132,831 | 106.99M |
| 483 | MCTA | Charming Medical Limited | 504.26M | -0.85% | 4,251,392 | 4.81M |
| 484 | TCMD | Tactile Systems Technology, Inc. | 504.01M | -3.18% | 302,628 | 350.31M |
| 485 | ENTX | Entera Bio Ltd. | 502.11M | -1.69% | 256,682 | 42.00K |
| 486 | SENS | Senseonics Holdings, Inc. | 495.96M | 1.63% | 855,450 | 48.55M |
| 487 | PRTA | Prothena Corporation plc | 493.35M | 2.78% | 267,670 | 54.53M |
| 488 | EVH | Evolent Health, Inc. | 483.89M | -4.89% | 2,830,152 | 2.10B |
| 489 | PBYI | Puma Biotechnology, Inc. | 482.65M | 2.63% | 458,304 | 231.24M |
| 490 | CCCC | C4 Therapeutics, Inc. | 476.11M | 4.31% | 2,364,277 | 35.04M |
| 491 | RLMD | Relmada Therapeutics, Inc. | 475.75M | 2.29% | 944,057 | - |
| 492 | SRTA | Strata Critical Medical, Inc. | 475.07M | -5.12% | 1,046,010 | 255.98M |
| 493 | KMDA | Kamada Ltd. | 474.61M | 1.82% | 173,003 | 191.85M |
| 494 | EDIT | Editas Medicine, Inc. | 471.49M | 0.33% | 1,227,017 | 47.01M |
| 495 | RZLT | Rezolute, Inc. | 470.10M | -4.05% | 1,020,715 | - |
| 496 | DNA | Ginkgo Bioworks Holdings, Inc. | 466.67M | 1.76% | 1,810,570 | 132.42M |
| 497 | ARCT | Arcturus Therapeutics Holdings Inc. | 461.16M | 9.93% | 1,368,244 | 29.37M |
| 498 | VOGX | Vogenx, Inc. | 461.09M | -2.56% | 338,690 | - |
| 499 | CLPT | ClearPoint Neuro, Inc. | 454.51M | -1.59% | 809,608 | 42.28M |
| 500 | EVMN | Evommune, Inc. | 452.93M | -1.42% | 278,492 | 10.00M |